Hyderabad Pharma Infrastructure and Technologies
About Hyderabad Pharma Infrastructure and Technologies
Data last updated:
Hyderabad Pharma Infrastructure and Technologies is a public not for profit company based in Hyderabad, Telangana, India. It operates in the equipment leasing and financing segment of the financial services sector. It was incorporated on 04 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U45200TG2005NPL045814. Its GSTIN is 36AABCH7419L2ZA (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Shakthi Meyyappan Nagappan (Managing Director) and Policepatil Bakkareddy.
Its last annual general meeting (AGM) was held on 23 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 6th Floor Parishrama Bhavanam Fatehmaidan Road, Hyderabad, Telangana, India – 500004.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.62 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹7.13 Lakh (net margin -40.5%) and EBITDA of -₹2.2 Lakh (EBITDA margin -12.5%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
CIN History of Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U45200TG2005NPL045814, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U45200TG2005NPL045814 | Current |
| U45200AP2005NPL045814 | Previous |
| U45200AP2005PLC045814 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address6th Floor Parishrama Bhavanam Fatehmaidan Road, Hyderabad, Telangana, India – 500004
- IndustryFinancial Services, Equipment Leasing & Financing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Hyderabad Pharma Infrastructure and Technologies
The main business activity of Hyderabad Pharma Infrastructure and Technologies is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hyderabad Pharma Infrastructure and Technologies FY 2024 filings available
Hyderabad Pharma Infrastructure and Technologies reported revenue of ₹17.62 Lakh (down 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Hyderabad Pharma Infrastructure and Technologies
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 14% fall in the latest year. EBITDA fell 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Hyderabad Pharma Infrastructure and Technologies
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.2 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹7.13 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hyderabad Pharma Infrastructure and Technologies
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -40.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hyderabad Pharma Infrastructure and Technologies are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies has 5 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Policepatil Bakkareddy Also directs: Jeedimetla Effluent Treatment Limited. | Nominee Director | 10 Apr 2019 | 7 Years 6 Months | Current |
| Kappuram Sunder Shyam Also directs: Maheshwaram Science Park Limited, Ecity Manufacturing Cluster Limited, Fab City SPV (India) Private Limited and 5 more | Nominee Director | 10 Apr 2019 | 7 Years 6 Months | Current |
| Anandakumar Reddy Attivarapu | Nominee Director | 10 Apr 2019 | 7 Years 6 Months | Current |
| Shakthi Meyyappan Nagappan Also directs: Telangana Life Sciences Infrastructure Development Limited, Hyderabad Pharma City Limited, Bio-Tech Hub Limited and 5 more | Managing Director | 10 Apr 2019 | 7 Years 6 Months | Current |
| Sreenivasu Garikapati | Nominee Director | 04 Mar 2022 | 4 Years 7 Months | Current |
Peer Comparison of Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies is compared with the companies closest to it by revenue in the BFSI industry (Machinery and Equipment Leasing). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mahamaya Vincom Private Limited | ₹18.01 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Serain Catel Builders Private Limited | ₹18 Lakh (FY 2022) | •••• | •••• | •••• | Bengaluru, Karnataka, India | |
| Star Lighting & Sound Private Limited | ₹17.97 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Mahavir Granites Private Limited | ₹17.79 Lakh (FY 2024) | •••• | •••• | 57.0% | •••• | Madurai, Tamil Nadu, India |
| Maruti Skilldevelopers India Limited | ₹17.64 Lakh (FY 2024) | •••• | •••• | 35180.0% | •••• | Bhilai, Chhattisgarh, India |
| Hyderabad Pharma Infrastructure and Technologies this company | ₹17.62 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Hyderabad, Telangana, India |
| VCS Ventures Private Limited | ₹17.6 Lakh (FY 2024) | •••• | •••• | 34.0% | •••• | Keonjhar, Odisha, India |
| Sahara Offshore Private Limited | ₹17.6 Lakh (FY 2025) | •••• | •••• | 47.0% | •••• | Mumbai, Maharashtra, India |
| KNS Infraservices Private Limited | ₹17.58 Lakh (FY 2025) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| K S Fiscal Services Pvt Ltd | ₹17.39 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Kolkata, West Bengal, India |
| Umrao Commercial Pvt Ltd | ₹17.38 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Hyderabad Pharma Infrastructure and Technologies by revenue in the BFSI industry (Machinery and Equipment Leasing), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies is audited by MURTHY AND PRASAD & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MURTHY AND PRASAD & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Hyderabad Pharma Infrastructure and Technologies
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies has 1 court case on record: 1 filed by Hyderabad Pharma Infrastructure and Technologies. All case is pending. Status as checked on 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against Telangana State Industrial Infrastructure Corporation Limited | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Hyderabad Pharma Infrastructure and Technologies
Employment history and EPFO contributions of people linked to Hyderabad Pharma Infrastructure and Technologies.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies has 19 board changes on record since 2011: 5 appointments and 14 cessations. The latest: Sreenivasu Garikapati was appointed as Nominee Director on 04 Mar 2022.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Hyderabad Pharma Infrastructure and Technologies
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hyderabad Pharma Infrastructure and Technologies
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hyderabad Pharma Infrastructure and Technologies
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCH7419L2ZA | Telangana | Active | 09 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hyderabad Pharma Infrastructure and Technologies
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hyderabad Pharma Infrastructure and Technologies
Hyderabad Pharma Infrastructure and Technologies is an active public not for profit company based in Hyderabad, Telangana, India. The company works in equipment leasing and financing, within the financial services industry. It was incorporated on 04 April 2005 (21+ years old) and is registered under CIN U45200TG2005NPL045814.
Hyderabad Pharma Infrastructure and Technologies reported revenue of ₹17.62 Lakh for FY 2024 (down 14% YoY).
Hyderabad Pharma Infrastructure and Technologies has 5 current directors:
- Shakthi Meyyappan Nagappan - Managing Director
- Policepatil Bakkareddy - Nominee Director
- Kappuram Sunder Shyam - Nominee Director
- Anandakumar Reddy Attivarapu - Nominee Director
- Sreenivasu Garikapati - Nominee Director
Hyderabad Pharma Infrastructure and Technologies reported a net loss of ₹7.13 Lakh (net margin -40.5%) and EBITDA of -₹2.2 Lakh (EBITDA margin -12.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Hyderabad Pharma Infrastructure and Technologies is 7% over three years and -4% over five years. In the latest year (FY 2024) revenue fell 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Hyderabad Pharma Infrastructure and Technologies is 36AABCH7419L2ZA, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Hyderabad Pharma Infrastructure and Technologies is U45200TG2005NPL045814. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hyderabad Pharma Infrastructure and Technologies has 1 court case on record: 1 filed by the company. 1 is pending.
Hyderabad Pharma Infrastructure and Technologies was incorporated on 04 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Hyderabad Pharma Infrastructure and Technologies by revenue are Mahamaya Vincom Private Limited, Serain Catel Builders Private Limited, Star Lighting & Sound Private Limited, Mahavir Granites Private Limited, Maruti Skilldevelopers India Limited and 5 more, all in the BFSI industry (Machinery and Equipment Leasing).
Sreenivasu Garikapati was appointed as Nominee Director on 04 Mar 2022. Shakthi Meyyappan Nagappan ceased to be Managing Director on 07 Apr 2021. Garikapati Narasimha Rao ceased to be Director on 26 Sep 2019. Hyderabad Pharma Infrastructure and Technologies has 19 board changes on record in total.